Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Phivida Holdings Inc. PHVAF

Healthcare Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Cannabis
Phivida is a premier brand of cannabidiol ('CBD')-infused functional foods, beverages and clinical products that is poised for global distribution.


OTCQX:PHVAF - Post by User

Phivida Holdings Inc. > Need a positive NR and this will pop
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(60)
•••
Comment by Doupahorseon May 03, 2019 11:11am
68 Views
Post# 29706604

RE:RE:Need a positive NR and this will pop

RE:RE:Need a positive NR and this will popEvident you are lying as short reports only releases twice a month and the next one will be 15th to accurately reflect 

This management is leaning the Ecommerce route.   I can only trust the decision 
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities